Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension

NCT00947661 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

578

Enrollment

INDUSTRY

Sponsor class

Conditions

Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: SPARC0912
DRUG: Reference0912

Sponsor

Sun Pharma Advanced Research Company Limited